Mesoblast Limited Key Product Franchises Featured at Nomura Asia Equity Forum

Melbourne, June 14, 2011 (ABN Newswire) - Global regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), was featured today at the 8th Nomura Asia Equity Forum being held in Singapore. Mesoblast was the only Australian company to present at the respected Asian investor forum.

MORE ON THIS TOPIC